Skip to Content


In the US, STRENSIQ (asfotase alfa systemic) is a member of the drug class miscellaneous metabolic agents and is used to treat Hypophosphatasia.

US matches:

UK matches:

Ingredient matches for STRENSIQ

Asfotase Alfa

Asfotase alfa is reported as an ingredient of STRENSIQ in the following countries:

  • Canada
  • Germany
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.